Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Soligenix Receives FDA Orphan Drug Designation For The Active Ingredient In SuVax, The Subunit Protein Vaccine Of Recombinantly Expressed Sudan Ebolavirus (SUDV) Glycoprotein, For The Prevention And Post-Exposure Prophylaxis Against SUDV Infection

Author: Benzinga Newsdesk | April 11, 2024 07:32am

Posted In: SNGX

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist